# DefEYE Partners with Lovell Government Services to Bring BIOVANCE Portfolio to Federal Healthcare Systems

> partnership · REPORTED · 2026-07-28

DefEYE, Inc. announced a partnership with Lovell to distribute its BIOVANCE portfolio of decellularized placental tissue products to federal healthcare systems, expanding access to its ocular biologics for military and VA patients. This follows the company's late-2025 seed investment from ExSight Ventures to accelerate commercialization.

About DefEYE, Inc.: DefEYE, Inc. is a privately held ophthalmic biologics company that commercializes decellularized placental tissue solutions, including BIOVANCE and BIOVANCE 3L Ocular, for the management of ocular surface diseases and surgical applications.

- Company: DefEYE™, Inc.
- Sector: medical devices
- Primary source: https://fox2now.com/business/press-releases/ein-presswire/856490409/defeye-inc-and-lovell-partner-to-bring-biovance-portfolio-to-federal-healthcare-systems

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.